BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?

被引：5

作者：

Bhatt, Hemal ^{[1
]}

Ghazi, Lama ^{[1
]}

Calhoun, David ^{[1
]}

Oparil, Suzanne ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA

来源：

CURRENT CARDIOLOGY REPORTS | 2016年 / 18卷 / 10期

关键词：

Hypertension; SPRINT; Blood pressure; Cardiovascular risk; Blood pressure treatment goals; Elderly; HIGH-BLOOD-PRESSURE; CORONARY-HEART-DISEASE; COGNITIVE FUNCTION; ASSOCIATION; TRIAL; PROGRESSION; EDUCATION; DEMENTIA; RISK; AGE;

D O I：

10.1007/s11886-016-0775-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systolic blood pressure (SBP) is an important predictor of cardiovascular disease (CVD) outcomes. Lowering SBP has been shown to reduce CVD morbidity and mortality, but the optimal SBP target continues to be a topic of intense debate. The Systolic Blood Pressure Intervention Trial (SPRINT) reported a significantly lower risk for CVD outcomes and all-cause mortality by targeting SBP < 120 mmHg compared with < 140 mmHg in a population of hypertensive persons at high CV risk. In this review, we discuss the strengths, limitations, and generalizability of SPRINT findings to other hypertensive populations that were excluded from the trial, including those with diabetes or prior stroke, < 50 years old, and at lower CVD risk. We will focus on the implications of SPRINT findings for appropriate BP targets in high-risk groups of hypertensive persons, including the elderly and those with chronic kidney disease (CKD). We will also address the cost-effectiveness of intensive BP treatment as implemented in SPRINT and the implications of SPRINT for health care policy and future BP guidelines.

引用

页数：8

共 51 条

[1] The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) [J].

Ambrosius, Walter T. ;

Sink, Kaycee M. ;

Foy, Capri G. ;

Berlowitz, Dan R. ;

Cheung, Alfred K. ;

Cushman, William C. ;

Fine, Lawrence J. ;

Goff, David C., Jr. ;

Johnson, Karen C. ;

Killeen, Anthony A. ;

Lewis, Cora E. ;

Oparil, Suzanne ;

Reboussin, David M. ;

Rocco, Michael V. ;

Snyder, Joni K. ;

Williamson, Jeff D. ;

Wright, Jackson T., Jr. ;

Whelton, Paul K. .

CLINICAL TRIALS, 2014, 11 (05) :532-546

[2]

[Anonymous], 1991, JAMA, V265, P3255

[3] Treatment of hypertension in patients 80 years of age or older [J].

Beckett, Nigel S. ;

Peters, Ruth ;

Fletcher, Astrid E. ;

Staessen, Jan A. ;

Liu, Lisheng ;

Dumitrascu, Dan ;

Stoyanovsky, Vassil ;

Antikainen, Riitta L. ;

Nikitin, Yuri ;

Anderson, Craig ;

Belhani, Alli ;

Forette, Francoise ;

Rajkumar, Chakravarthi ;

Thijs, Lutgarde ;

Banya, Winston ;

Bulpitt, Christopher J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898

[4] Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial [J].

Benavente, O. R. ;

Coffey, C. S. ;

Conwit, R. ;

Hart, R. G. ;

McClure, L. A. ;

Pearce, L. A. ;

Pergola, P. E. ;

Szychowski, J. M. ;

Benavente, O. R. ;

Hart, R. G. ;

Pergola, P. E. ;

Palacio, S. ;

Castro, I. ;

Farias, A. ;

Roldan, A. ;

Kase, C. ;

Gavras, I. ;

Lau, H. ;

Ogrodnik, M. ;

Allen, N. ;

Meissner, I. ;

Graves, J. ;

Herzig, D. ;

Covalt, J. ;

Meyer, B. ;

Jackson, C. ;

Gamble, P. ;

Kelly, N. ;

Warner, J. ;

Bell, J. ;

Demaerschalk, B. ;

Hogan, M. ;

Wochos, D. ;

Wieser, J. ;

Cleary, B. ;

Wood, L. ;

Hanna, J. ;

Zipp, T. ;

Bailey, S. ;

Cook, D. ;

Liskay, A. ;

Simcox, D. ;

Kappler, J. ;

Anderson, D. ;

Grimm, R. ;

Brauer, D. ;

Pettigrew, C. ;

Vaishnov, A. ;

Sawaya, P. ;

Fowler, A. .

LANCET, 2013, 382 (9891) :507-515

[5] Generalizability of SPRINT Results to the US Adult Population [J].

Bress, Adam P. ;

Tanner, Rikki M. ;

Hess, Rachel ;

Colantonio, Lisandro D. ;

Shimbo, Daichi ;

Muntner, Paul .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (05) :463-472

[6] Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses [J].

Brunstrom, Mattias ;

Carlberg, Bo .

BMJ-BRITISH MEDICAL JOURNAL, 2016, 352

[7] Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].

Calhoun, David A. ;

Jones, Daniel ;

Textor, Stephen ;

Goff, David C. ;

Murphy, Timothy P. ;

Toto, Robert D. ;

White, Anthony ;

Cushman, William C. ;

White, William ;

Sica, Domenic ;

Ferdinand, Keith ;

Giles, Thomas D. ;

Falkner, Bonita ;

Carey, Robert M. .

HYPERTENSION, 2008, 51 (06) :1403-1419

[8] White coat hypertension: not so benign after all? [J].

Chung, I ;

Lip, GYH .

JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (12) :807-809

[9] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].

COLLINS, R ;

PETO, R ;

MACMAHON, S ;

HEBERT, P ;

FIEBACH, NH ;

EBERLEIN, KA ;

GODWIN, J ;

QIZILBASH, N ;

TAYLOR, JO ;

HENNEKENS, CH .

LANCET, 1990, 335 (8693) :827-838

[10] SPRINT Trial Results Latest News in Hypertension Management [J].

Cushman, William C. ;

Whelton, Paul K. ;

Fine, Lawrence J. ;

Wright, Jackson T. ;

Reboussin, David M. ;

Johnson, Karen C. ;

Oparil, Suzanne .

HYPERTENSION, 2016, 67 (02) :263-265

← 1 2 3 4 5 6 →